Wednesday, February 01, 2017 7:58:18 AM
Analysts' Ratings History for Idera Pharmaceuticals (NASDAQ:IDRA)
Show:
Date Firm Action Rating Price Target Details
1/31/2017 Wedbush Initiated Coverage Outperform $6.00 View Rating Details
11/29/2016 Cowen and Company Reiterated Rating Outperform View Rating Details
10/7/2016 S&P Equity Research Boost Price Target $1.86 -> $2.10 View Rating Details
3/12/2016 Piper Jaffray Companies Reiterated Rating Buy View Rating Details
6/15/2015 J P Morgan Chase & Co Initiated Coverage Overweight $6.00
IDRA
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM